Trademark: 88057861
Status Date
Monday, November 7, 2022
Filing Date
Monday, July 30, 2018
Published for Opposition
Tuesday, August 6, 2019
Abandoned Date
Monday, November 7, 2022
9 Downloadable software and mobile applications for genetic assessment and identification of cancer, cancer ailments, and cancer mutations for scientific, medical, diagnostic, treatment, and research purposes, for creating local databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for creating, accessing, and using online databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for recording, analyzing, storing, manipulating and organizing genetic and molecular data, and for providing access to multiple online databases that contain aggregated results of molecular biology testing and genotyping; medical testing products, namely, downloadable vaccination test forms
5 Medical testing products, namely, modified immune cells; Medical testing products, namely, modified immune cells for use in connection with various cancers with genetic treatments
16 Medical testing and treatment products, namely, printed test forms and printed user information inserts for medical products; Medical testing products, namely, printed vaccination test forms
44 Providing medical diagnostic and treatment services, namely, tumor detection in the form of a liquid biopsy; medical diagnostic and treatment services in the nature of tumor analysis, diagnosis, and identification in the form of sequenced tissue identification, and tumor medical treatment therapy in the form of identification of appropriate combination of mutations for targeted cancers and identification of appropriate treatments targeted for those combination of mutations via modified T-Cells in the form of other treatments to inhibit expressions of those combination of mutations and to modify one or more of the mutations in the combination
10 Medical testing and treatment products in the form of treatment therapies, namely, apparatus for medical diagnosis, drug delivery apparatus and genetic delivery apparatus all for various cancers with genetic treatments and specimen collection tubes and containers for collecting patient specimens, namely, blood, urine, saliva, and tissue, for genomic sequencing and for detection of gene mutations, gene expression profiles or other molecular indicators or markers associated with cancer or risk of developing cancer; Medical testing and treatment product kits containing blood specimen collection tubes and containers for collecting patient blood specimens for genomic sequencing and detection of gene mutations, gene expression profiles or other molecular indicators or markers associated with cancer or risk of developing cancer modified immune cells and treatment therapies, and also containing modified immune cells, treatment therapies, test forms, mailing materials and user information inserts
42 Providing online non-downloadable software and software programs for genetic assessment and identification of cancer, cancer ailments, and cancer mutations for scientific, medical, diagnostic, treatment, and research purposes, for creating online databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for creating, accessing, and using online databases of genomic sequences, cancer ailments, and cancer mutations for tracking, matching, searching, testing, aggregating, researching, and diagnosing cancer, cancer ailments, and cancer mutations, for recording, analyzing, storing, manipulating and organizing genetic and molecular data, and for providing access to multiple online databases that contain aggregated results of molecular biology testing and genotyping
Nov 7, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 7, 2022
Abandonment - No Use Statement Filed
Apr 13, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 12, 2022
Sou Extension 5 Granted
Apr 1, 2022
Sou Extension 5 Filed
Apr 1, 2022
Sou Teas Extension Received
Sep 30, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 28, 2021
Sou Extension 4 Granted
Sep 28, 2021
Sou Extension 4 Filed
Sep 28, 2021
Sou Teas Extension Received
Apr 2, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 31, 2021
Sou Extension 3 Granted
Mar 31, 2021
Sou Extension 3 Filed
Mar 31, 2021
Sou Teas Extension Received
Oct 2, 2020
Notice Of Approval Of Extension Request E-Mailed
Sep 30, 2020
Sou Extension 2 Granted
Sep 30, 2020
Sou Extension 2 Filed
Sep 30, 2020
Sou Teas Extension Received
Apr 3, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 2, 2020
Sou Extension 1 Granted
Mar 31, 2020
Sou Extension 1 Filed
Apr 2, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 2, 2020
Case Assigned To Intent To Use Paralegal
Mar 31, 2020
Sou Teas Extension Received
Mar 31, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 31, 2020
Teas Change Of Correspondence Received
Mar 31, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 31, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 31, 2020
Teas Change Of Owner Address Received
Oct 1, 2019
Noa E-Mailed - Sou Required From Applicant
Aug 6, 2019
Official Gazette Publication Confirmation E-Mailed
Aug 6, 2019
Published For Opposition
Jul 17, 2019
Notification Of Notice Of Publication E-Mailed
Jul 3, 2019
Approved For Pub - Principal Register
Jul 3, 2019
Examiner's Amendment Entered
Jul 3, 2019
Notification Of Examiners Amendment E-Mailed
Jul 3, 2019
Examiners Amendment E-Mailed
Jul 3, 2019
Examiners Amendment -Written
Jul 1, 2019
Previous Allowance Count Withdrawn
Jun 18, 2019
Withdrawn From Pub - Og Review Query
May 31, 2019
Law Office Publication Review Completed
May 30, 2019
Assigned To Lie
May 16, 2019
Approved For Pub - Principal Register
May 16, 2019
Examiner's Amendment Entered
May 16, 2019
Notification Of Examiners Amendment E-Mailed
May 16, 2019
Examiners Amendment E-Mailed
May 16, 2019
Examiners Amendment -Written
Apr 30, 2019
Teas/Email Correspondence Entered
Apr 29, 2019
Correspondence Received In Law Office
Apr 29, 2019
Teas Response To Office Action Received
Nov 26, 2018
Notification Of Non-Final Action E-Mailed
Nov 26, 2018
Non-Final Action E-Mailed
Nov 26, 2018
Non-Final Action Written
Nov 15, 2018
Assigned To Examiner
Aug 3, 2018
New Application Office Supplied Data Entered
Aug 2, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
